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Chase reported more than 25 years ago that
immunological unresponsiveness to several con-
tact sensitizers could be induced in the adult
guinea pig by feeding (1). This was demon-
strated by showing that guinea pigs which
had previously been fed 2:4 dinitrochloro-
benzene (DNCB) could not be sensitized
when they were subsequently given a series of
intradermal injections of DNCB which regu-
larly induced a high level of sensitivity in
control animals.
This discovery of Chase in the guinea pig
has subsequently been expanded by many
workers (2—4). It had been shown that un-
responsiveness may be induced by intravenous
exposure to the sensitizer, as well as by feed-
ing (5, 20). We have recently shown that, when
a contact sensitizer is applied to the skin of
the guinea pig, both sensitivity and unre-
sponsiveness may be induced at the same time
(6).
Until now attempts to demonstrate the
Chase effect in man by feeding a contact
sensitizer to subjects before carrying out a
conventional sensitizing procedure have not
been successful (7, 8). The prevention of the
humoral response to Rh antigens by adminis-
tration of anti-Rh globulins, which has been
demonstrated in man (9), is a different form
of unresponsiveness in that delayed hyper-
sensitivity has not been shown to be involved.
However, in a previous study we described
two subjects who were given DNCB by ap-
plication to the buccal mucosa for several weeks
before being subjected a series of topical ap-
plications which sensitized control subjects
(10). One of these two subjects was not sensi-
tized by the series of topical applications,
while the second was sensitized, but to a
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METHODS
Subjects in these experiments were 43 male
prisoners.t Data concerning the age and race of
subjects in our two groups are presented in Table
I.
The sensitizer used was 2,4—dinitrochlorobenzene
(DNCB) purchased from Eastman Chemical Com-
pany. This compound was weighed out in small
amounts and dissolved in acetone as needed so
that no solution was kept for more than 2 hrs.
The probity of sensitizing human subjects to
DNCB has been discussed by us previously (10).
The possibility that DNCB could have systemic
toxic effects when applied to the buccal mucosa
was considered. However, we never gave more than
750y by this route at one time, and did not give
any one subject more than 7.5 mgm during the
series of buccal applications which extended over
a period of several months. Although there is no
doubt whatever that DNCB is a toxic compound
if given in large doses, we present the following
evidence that our doses were not in the toxic
range:
1. Guinea pigs have been given, by feeding
or stomach tube, total doses as great as 270
mgn DNCB by Coe (11) and 54 mgrn by
Chase (12) without gross signs of toxicity. It
must be remembered that the weight of a guinea
pig is about 1/150th that of a man, so that 270
rngm fed to a guinea pig is the equivalent on a
weight basis of 40,000 mgm fed to a man. We
gave our adult subjects weekly doses of .75
mgnh.
2. DNCB is quite readily absorbed from the
human skin, so that the likelihood of toxicity
from buccal application is not much greater
than that following topical application. Feld-
man and Maibach report that 57.8% of a
topically applied dose of DNCB was absorbed
(13). This means that our application of 750y
to the mucosa, even if completely absorbed,
cannot result in a larger systemic dose than
that resulting from application of 1.5 mgm to
the skin. It is common practice to apply
t I am greatly indebted to William Wingfield,
M.D. and to David Pollack, M.D. for their gener-
ous cooperation with this project.
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minimal degree. Observation of these two sub-
jects suggests that immunological unresponsive-
ness to an antigen inducing delayed hyper-
sensitivity can be demonstrated in the adult
human, The present study verifies this hypothe-
sis.




N Median Range Whiie Negro
Exptl. 17 28 23—53 10 7
Control 26 33 21—55 17 9
DNCB or dinitrofluorobenzene to the skin in
milligram amounts to sensitize patients sus-
ported of a defect in delayed sensitivity; many
such patients are small children with agamma—
globulinemia (14, 15) or infants with agamma-
globulinernia of the Swiss type (16). Two
milligrams of DNCB applied to the skin of a
10 lb. infant is equivalent by weight to 16 mgm
given systemically to a 160 lb. man, even if only
50% of the topical dose were absorbed.
3. Dinitrophenol, a closely related compound,
was widely used to induce weight loss some
years ago. That compound produced systemic
toxic effects, but was given in doses of 200—500
mgm daily for prolonged periods. Our doses of
7SOy DNCB per week were approximately .1
rngm a day, more than a thousand-fold less.
4. SGOT determinations were performed one
day after the last buccal administration of
DCB in 1Q of our 17 subjects, and all yielded
norma' values. Urinalysis, WBC, and differential
leukocyte count, all within normal limits, were
obtained at the same time from 4 of these
subjects.
Mucosal administration of DNCB was accom-
plished by pipetting 750y DNCB in a 2% acetone
solution onto one side of the open mouth. The
head was tilted so that the buccal surface was
level during application, and alternate sides of
the mouth were treated each week. Subjects were
instructed to take 12 deep breaths with the mouth
oprn after each application to help evaporate the
acetone. Care was taken to avoid touching the
lips with the solution, and each subject swallowed
a few sips of water after the application so that
the chemical could not be spit out after leaving
the room.
Of the 17 subjects given DNCB by the buccal
route, 6 received 10 weekly applications (7,500y);
4 received S weekly applications (6,000y); 6
received S applications of which tbe first 5 were
at 2-week intervals and the last 3 given weekly;
and the last subject received only 5 bi—weekly
applications, after which the series was discon-
tinued because of evidence of sensitization (uni-
lateral stomatitis). One week after the last buccal
appliration of DNCB, topical application was
begun.
Topical application of DNCB.—Both control
and experimental subjects were given identical
apulications of 5th' DNCB (dissolved in .01 ml
acetone) to circles 1 cm in diameter stamped in
ink. Three such applications were made to the
skin of the lateral aspect of each arm and the
anterior aspect of each leg just above the knee,
each week for 5 weeks. Thus, 12 applications of
50y each, or 600y DNCB were applied to the skin
each week. Subjects not sensitized within 5 weeks
were then given 5 applications of SOy to each
extremity (20 applications, or 1 mgm weekly)
for another 5 weeks. This series of topical appli-
cations was discontinued after sensitivity appeared
except that 7 of the 9 subjects in the buccal
exposure group who were sensitized completed the
s3ries of 10 topical applications. Thus, all but 2
of the 17 subjects in the buccal exposure group
were subjected to the entire series of topical ap-
plications. Those subjects who exhibited no evi-
dence of contact sensitivity by the lQth topical
application were given additional applications of
SOy, 1007, and 150y DNCB applied as tests to
circles 1 cm in diameter on the lateral aspect of
the arm one month later to detect sensitivity
which may have appeared after the series of 10
applications was completed.
Quantilation of sensitivity
The intensity of sensitivity was measured by a
graded series of epicutaneous tests consisting of
application of the following quantities of DNCB
in acetonic solution to circles 1 cm in diameter:
SOy, 25y, 5y, 2y, 17, .47. This series was applied
without occlusion to the inner aspect of the arm
(Fig. 1). All subjects were tested approximately
one week after sensitivity appeared. Control sub-jects were tested again on the other arm about
one month later. Subjects in the buccal group who
were willing to continue receiving the series of
topical applications after having become sensitized
were retested after the 4th and after the 10th
applications.
All tests were read 3 and 7 days after applica-
tion and were quantitated in two ways:
1. Lowest eliciting dose was determined for
each subject on each test. This was the smallest
amount of DNCB in the test series which
elicited a detectable erytherna. Occasionally the
weekly application of SOy to the lateral arm
or anterior leg elicited a visible reaction, indi-
cating sensitization, but the ensuing test series
applied to the inner arm (which, in our experi-
ence, is a less sensitive area) was completely
negative. Such cases are assigned a threshhold
score of "50y+", as more than SOy DNCB would
have been required to detect the induced sensi-
tivity in the test area.
2. Total score was obtained by adding scores
for each individual test site, which were graded
as described previously (10).
RESULTS
Sensitization induced by buccal application
of DNCB. Seven of the 17 subjects so treated
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FIG. 1. Series of test reactions on subject in control group, 3 days after application of
the following amounts of DNCB to test sites (read clockwise from 11 o'clock): 5O'y, 25y,
1Oy,5y, 2y, ly, and .4y. Note flare extending around the first 3 tests. This subject was
sensitive to as little as .4y DNCB, which was his lowest eliciting dose.
were sensitized by application of DNCB to
the buccal mucosa. One subject developed uni-
lateral stomatitis following the fifth oral appli-
cation, and subsequently exhibited a positive
skin test to DNCB. The other 6 sensitized
subjects completed the course of oral applica-
tions without stomatitis but did react to the
first topical application of DNCB, showing
that they had been sensitized by the per-
mucosal route. Our observations are con-
sistent with the demonstratiois of the Memphis
group (17) that contact sensitivity can be
iiduced by per-mucosal administration of
DNCB to animals. Although we are reasonably
certain that DNCB applied to the buccal
mucosa did not come into contact with the
skin of the lips, contact with perianal skin
may have occurred.
The one subject who presented a visible or
symptomatic stomatitis in response to DNCB
was the one member of the experimental group
who was most intensely sensitive by skin test.
Our experience is in accord with the coicept
that tile oral mucous membrane is a very in-
adequate medium for reflecting contact sensi-
tivity, and any mucosal reaction to a contac-
tant will be associated with a much more
intense response on the skin. We have no
evidence, therefore, for a "mucosal" sensitivity
which may exist independent of "cutaneous"
sensitivity.
Sensitization induced by topical application
of DNCB. All but one of our 26 control
subjects who were subjected to a series of 10
weekly topical exposures to DNCB without
prior inucosal exposure developed evidence of
contact sensitivity. Fifteen of these were
sensitized by the first 2 applications; others
developed sensitivity at varying points over the
10 week period.
In contrast, although 7 of the experimental
subjects had been sensitized by mucosal ad-
ministration of DNCB, additional exposure to
the compound by the topical route induced
contact sensitivity in only 2 more. The re-
maining S subjects showed no sign of contact
reaction to DNCB at any time during or after
the 10 weeks of topical exposure. There was no
apparent relationship between the number of
buccal applications and the iicidence of un-
respolisiveness.
These data are presented graphically in
Table II. The statistical reliability of the dii-.
ference in incidence of unresponsiveness in
these two groups is obvious at a glance; Chi-
square analysis shows that the occurrence by
chance of this difference is highly improbable
(P <.005).
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Intensity of sensitivity. The degree of con-
tact sensitivity induced in each subject is
presented in Figure 2, in which the results of
the first test series applied after the appearance
of sensitivity are depicted. It is apparent from
these data that those subjects who were
initially exposed to DNCB by the buccal
route, even if they were sensitized, did not
become highly sensitive.
Furthermore, those subjects in whom a weak
degree of sensitivity appeared following buccal
exposure developed only slightly more intense
sensitivity during the subsequent series of
topical applications of DNCB (the series of 10
applications was continued in spite of mild
local allergic reactions in all but 2 of the
experimental subjects). Thus, even those sub-
jects who were sensitized were partially un-
responsive to topical applications of DNCB;
otherwise they would have become as highly
sensitive as the control subjects did with the
same exposure. These findings are presented in
Figures 3 and 4, in which the results of
epicutaneous tests conducted after 4 and after
26 10 weeks of topical exposure are presented.
The Mann-Whitney "U" test shows that the
differences in level of sensitivity of the sensi-
tized subjects in each group were statistically
reliable at the 4-week evaluation (P < .01).
The difference in levels of sensitivity of sensi-
tized subjects in the two groups after 10 weeks
of topical exposure was not statistically re-
liable.
Data presented are based on reading of tests
at 3 days; 7-day readings revealed the same
picture. When test readings are evaluated in
terms of "total score" rather than as "least
eliciting dose", an identical picture is seen. In
both cases, all differences are of equal or greater
statistical reliability.
We cannot explain the attenuation of the
level of contact sensitivity observed after
buccal administration of DNCB by any fac-
tor, other than unresponsiveness. Table I shows

















FIRST Rx NONE BUCCAL
SECOND Rx TOPICAL TOPICAL
Fjc;. 2. Level of sensitivity in control and ex-
perimental groups. Each dot represents one sub-ject, and designates the lowest eliciting dose of
DNCB on the first test given after the appearance
of sensitization.
"507+" designates subjects who were sensitized(as shown by reaction to "sensitizing" applications
of DNCB to the lateral arm) but who failed to
react to the largest dose (507) on the test series
applied to the inner aspect of the arm.
"N.S." refers to subjects who were not sensitized

















HRST Rx NONE BUCCAL
SECOND Rx TOPICAL TOPICAL
Fm. 3. Level of sensitivity seen after 4 weekly
topical applications of DNCB. At this time, 8 of
the 26 control subjects had not yet become
sensitized, although all but one were sensitized by
the 10th application (Fig. 4). The level of sensi-
tivity induced by buccal application has shown a
rise in a few subjects. "?" represents one subject
sensitized by the bucca route who did not submit
to 4 topical exposures, so that the level of sensi-
tivity which would have been induced in him is
not known.
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for age and race. There is nO noticeable dif-
ference between the two groups in allergic
history, medical history, education, or occupa-
tion. Although most of those subjects who
developed very intense sensitivity were white
males under 30, 6 of the 17 experimental sub-
jects, but only 7 of the 26 controls, were in
this category. The series of topical applications
was begun at the same time (October or
February) in both groups with the exception
of 6 control subjects in whom sensitization
was begun in the summer. However, these 6
subjects tended to be less readily sensitized
than did controls sensitized in cooler weather;
(the one control subject who was never sensi-
tized was exposed in the summer), and their
inclusion in the experiment tends to diminish
the difference between groups, rather than to
explain it.
We have not directly demonstrated the
specificity of the unresponsiveness which we
observed, as we did not show that our un-
responsive subjects could be sensitized to an
unrelated antigen. However, the likelihood that
the snull doses of DNCB we gave induced
systemic toxicity which resulted in a gen-
eralized immunological incompetency is negli-
gible. IDe Weck et al. (5) as well as a number
of other investigators have given much larger









evidence for impairment of responses to un-
related antigens. Furthermore, we have shown
that the application of larger doses of IDNCB
to the skin appears to result in an increase,
not in a decrement in intensity of immuno-
logic response (10). It would be remarkable
indeed if such a small amount of IDNCB should
be found to induce a generalized immunological
impairment in man, but not in the guinea
pig, and even in man do so when given orally,
but not when given by the topical route.
We have not yet carried out studies of the
serologic response to buccal exposure to
DNCB. Such information may prove to be
pertinent. Extensive studies of the Chase
effect in the guinea pig, however, point toward
cellular rather than humoral explanations of
the unresponsiveness observed (2, 5). The
duration of this unresponsiveness is another
factor of importance which has not yet been
explored.
DISCUSSION
It is commonly, and erroneously assumed
that unresponsiveness and sensitivity are
mutually incompatible events. This study
clearly shows that, in man, as in the guinea
pig, both phenomena may be induced together.
Application of IDNCB to the oral nnicosa in-
duces a substantial degree of unresponsiveness,
but at the same time, the same procedure in-
duced a very low degree of sensitivity in
almost half of the subjects.
From information available to us from
previous studies of contact sensitivity in the
guinea pig (5, 6), it seems that unresponsive-
ness to a contact sensitizer appears after ex-
posure to the compound by almost any route
(intravenous, oral, or topical), while sensi-
tivity is induced most effectively by topical
exposure (or injection with an adjuvant), and
is negligible following administration by other
routes. This generalization parallels the com-
mon observation that, if sensitization is not in-
duced by the first exposure to an adequate
amounìt of a sensitizer, additional exposures
given two or three iveeks later, even if the
topical route is used, will not induce sensi-
tivity, for unresponsiveness will have set in.
(Of course, if the initial exposure is not
quantitatively adequate, unresponsiveness will
not be induced, and the subject can still be















FIRST Rx NONE BUCCAL
SECOND Rx TOPICAL TOPICAL
FiG. 4. Level of sensitivity induced in experi-
mental subjects by 10 weekly topical applications
of DNCB. Some increase in sensitivity is seen
(compare with Fig. 2). Two subjects (representedby "?") did not complete the series of topical
applications. Control subjects were not subjected
to additional weekly topical applications after they
were sensitized, and the level of sensitivity seen
on the first test series is shown for comparison.
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is seen in the present control group, and has
been reported in man several times (8, 10,
18). Thus, it is very possible that the ease with
which unresponsiveness can be induced in man
by the permucosal route is due to the happen-
stance that it is difficult to induce good sensi-
tivity in this way. Studies in progress suggest
that unresponsiveness can be induced in man by
the topical route as well, if methods of applica-
tion which minimize the degree of sensitization
are used.
Another way to conceptualize this is to state
that contact sensitivity occurs as a primary
response, but exhibits no secondary response.
Tims, if a very low or undetectable degree of
sensitivity is induced (as may occur following
per-mucosa exposure), the intensity of sensi-
tivity remains fixed near that level regardless
of further sensitizing exposures.
Alteration of the activity of the reticulo-
endothelial system, as of the nervous system,
by acquisition of specific information from the
environment, is a form of "learning". In the
study of either system, simple observation can
lead to rules which enable one to predict what
will occur. Such empirical rules are not perfect,
but they can be worked out and applied long
before immimochernical or neurophysiological
explanations of the same occurrences are forth-
coming. Such a behavioristic approach should
prove as useful in immunology as it has in the
study of learning (19).
Although our analysis of the factors which
control the appearance of unresponsiveness is
far from complete, demonstration of the ex-
istence of such a simple way to attenuate con-
tact sensitivity in man raises a number of
intriguing questions about the application of
this principle in other areas of immunology:
Can clinically significant contact sensitivity
be prevented or reduced by oral exposure to
the sensitizer prior to sensitizing exposures?
Perhaps we will be able to prevent poison ivy
sensitivity by feeding the antigen to infants
prior to the age of exposure.
Can the type and severity of allergic re-
actions to drugs be controlled by manipulating
the iiature of the initial exposure to the drug?
Conceivably, we will find that a drug given
initially by mouth is less likely to induce
allergic reactions of the delayed type than the
same drug given parenterally, regardless of the
route of administration used subsequently.
Contact sensitivity is mediated by mecha-
nisms very similar to those responsible for the
homograft reaction. Perhaps after we have
worked out the most efficient dosage schedules
for producing unresponsiveness to contact
sensitizers, the same principles can be applied
with success to the problem of inducing
specific unresponsiveness to tissue antigens.
SUMMARY
Small weekly doses of DNCB were applied
to the buccal mucosa of 17 adult male subjects.
Thereafter, these 17 subjects, plus an addi-
tional 26 control subjects were given a sensi-
tizing series of topical applications of DNCB.
The intensity of the sensitivity which resulted
was measured by a graded series of epicutane-
ous tests.
A mild degree of contact sensitivity was
induced by per-mucosal exposure to DNCB in
7 of the 17 subjects. Further exposure to
DNCB by the topical route raised this level of
sensitivity only slightly.
Eight of the 17 subjects who were given
DNCB by the buccal route were never sensi-
tized by the complete series of topical appli-
cations. The same topical series induced con-
tact sensitivity in 25 of the 26 control
sub)ects.
Both the lower incidence of sensitization, and
the lower intensity of sensitivity in those who
were sensitized, following buccal application of
DNCB were statistically significant.
This evidence shows that unresponsiveness
to a contact sensitizer can be induced in the
adult human, as well as in the adult guinea
pig.
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